Research-use-only context. This article summarizes published third-party scientific literature and laboratory practice. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. US Prime Peptides products are supplied strictly for in vitro laboratory research and are not for human or veterinary use.
A lyophilized peptide is a salt, and the anion that balances its positive charges is decided by how it was made and cleaned up. This article explains where trifluoroacetate comes from, why it matters for cell-based work and spectroscopy, how laboratories exchange it for acetate or chloride, how residual counter-ion is measured, and how the salt form should be declared on a certificate.
What the counter-ion on a peptide is
The counter-ion is the negatively charged partner that accompanies each positive charge on a peptide in its solid, salt form. A peptide with a free N-terminus and several lysine, arginine or histidine residues carries several positive charges at the acidic pH of its purification, and electrical neutrality requires an equal number of anions in the dried powder. Which anion is present depends on the last acid the peptide saw before drying. For nearly all synthetic peptides, that acid is trifluoroacetic acid, and the product is a trifluoroacetate (TFA) salt unless the maker exchanges it.
The counter-ion is not a contaminant in the usual sense. It is a stoichiometric part of the powder, and it has mass. A trifluoroacetate anion weighs 113 Da, an acetate anion 59 Da, a chloride anion 35.5 Da. A peptide with five basic sites held as the TFA salt therefore carries about 565 Da of counter-ion per molecule, which for a 1,400 Da peptide is more than a quarter of the weighed mass. That is why the salt form appears in the net peptide content calculation and why a vial labeled by gross mass holds less peptide than the number suggests; our article on net peptide content versus purity works through the arithmetic.
Where TFA comes from
TFA enters a synthetic peptide at two steps of standard solid-phase synthesis. First, in Fmoc chemistry the finished chain is cleaved from the resin, and its side-chain protecting groups removed, by a cocktail that is typically 90 to 95 percent TFA with scavengers. Second, the crude product is purified by reversed-phase HPLC with 0.1 percent TFA in both mobile phases, where it acts as an ion-pairing agent that sharpens peptide peaks. The collected fractions are frozen and lyophilized; the volatile TFA evaporates, but the trifluoroacetate anions paired with the peptide's basic sites stay behind. Erckes, Streuli, Chamera Rendueles, Krämer and Steuer summarized this route in a 2025 Pharmaceuticals paper and noted that the result, peptides supplied as TFA salts, is the default across the industry.
Manufacturer technical notes agree on the range. GenScript's TFA exchange service page states that most custom peptides are delivered as lyophilized TFA salts containing as much as 10 to 45 percent TFA by mass, and JPT's TFA removal page gives the same 10 to 45 percent figure, with the exact value depending on the number of basic residues in the sequence. A short, highly cationic antimicrobial peptide sits at the high end; a peptide with one lysine and an acetylated N-terminus sits at the low end.
The sequence notation on a label does not reveal the salt. A product described simply as "BPC-157" or "NN9535" may be either salt form; only an explicit "acetate" or "trifluoroacetate" in the name, or a counter-ion line on the certificate, tells you. The article on reading a peptide sequence explains how salt forms and other modifiers are written.
Why TFA matters for cell work and spectroscopy
Trifluoroacetate is not inert in biological assays, and the most cited demonstration is a 1999 American Journal of Physiology paper by Cornish and colleagues. They found that TFA alone, at 10-8 to 10-7 molar, reduced cell numbers and thymidine incorporation in fetal rat osteoblast cultures over 24 hours, with similar effects in articular chondrocytes and neonatal mouse calvarial cultures. When they compared the TFA and hydrochloride salts of amylin, amylin(1-8) and calcitonin in osteoblasts, the TFA salts consistently gave lower proliferation, enough to mask a proliferative effect or to produce a spurious antiproliferative one. Their conclusion was that any peptide used above 10-9 molar in a cell system should first be converted to a hydrochloride or an equivalent salt.
Later papers extended the point to other systems. Tipps, Iyer and Mihic reported in a 2012 Neuropharmacology paper that trifluoroacetate acts as an allosteric modulator at the glycine receptor expressed in Xenopus oocytes, at concentrations consistent with those carried in by TFA-salt peptides. Sikora and colleagues compared acetate, hydrochloride and trifluoroacetate salts of five antimicrobial peptides in a 2018 Amino Acids paper and found substantial differences in antistaphylococcal activity and in cytotoxicity toward a human keratinocyte line, with no consistent pattern across peptides. Gaussier and colleagues showed in 2002 that replacing TFA with HCl during purification of the bacteriocin pediocin PA-1 changed the peptide's secondary structure and activity, a structural effect of the counter-ion itself.
The second problem is spectroscopic. Trifluoroacetate has a strong infrared absorption at 1673 cm-1, directly on top of the amide I band (1600 to 1700 cm-1) that is used to read peptide secondary structure. Andrushchenko, Vogel and Prenner described the interference in a 2007 Journal of Peptide Science paper and Roux and colleagues confirmed it in 2008; for any FT-IR or circular dichroism study, TFA removal is a prerequisite rather than a refinement.
How salt exchange is done
Counter-ion exchange replaces trifluoroacetate with a different anion by repeatedly dissolving the peptide in a solution of the new acid and lyophilizing it. The classical method uses hydrochloric acid, because HCl (pKa about -7) is a much stronger acid than TFA (pKa about 0.3), so chloride displaces trifluoroacetate and the volatile TFA is pumped away. Andrushchenko and colleagues found in 2007 that the commonly recommended 0.1 molar HCl can alter peptide secondary structure and reduce thermal stability, and that 2 to 10 millimolar HCl removed essentially all TFA from the antimicrobial peptide indolicidin without that damage. Erckes and colleagues reached the same optimum, 10 millimolar HCl, in their 2025 systematic study, and saw no loss of purity at any HCl concentration tested.
Roux and colleagues, working with the dicationic octapeptide lanreotide in 2008, compared three alternatives to the HCl route: reversed-phase HPLC with the new counter-ion in the mobile phase, an anion-exchange resin, and a deprotonation and reprotonation cycle through a basic solution. The first two gave partial to near-complete exchange for a weaker acid such as acetic acid (pKa 4.76), and the third removed trifluoroacetate completely. The attraction of these routes is that they can install acetate, which the HCl method cannot do directly.
| Salt form | Parent acid pKa | Anion mass (Da) | How it gets there | Notes for laboratory work |
|---|---|---|---|---|
| Trifluoroacetate (TFA) | about 0.3 | 113.0 | Default from cleavage and RP-HPLC | Can affect cell assays at nanomolar levels; interferes with IR at 1673 cm-1; 10 to 45 percent of mass |
| Acetate | 4.76 | 59.0 | Ion exchange or RP-HPLC with acetate buffers; preferred for biological work per manufacturer notes | Weaker acid, milder on reconstitution; the form used for most approved peptide drug substances |
| Hydrochloride | about -7 | 35.5 | Lyophilization from dilute HCl (2 to 10 mM optimum) | Lowest mass penalty; the 1999 Cornish study used this form as the comparator |
| Formate | 3.75 | 45.0 | RP-HPLC with formic acid mobile phase | Common for MS-compatible purification; offered by some custom-synthesis vendors |
How residual counter-ion is measured
Residual trifluoroacetate is measured by a fluorine-specific or anion-specific method, not by the HPLC purity assay, because trifluoroacetate does not absorb at the wavelengths used for peptide detection and is invisible in a UV chromatogram. The 2025 Pharmaceuticals study validated three methods for the purpose under ICH guidelines: 19F nuclear magnetic resonance, which sees only the CF3 group and gives a direct molar ratio against an internal standard; FT-IR, using the 1673 cm-1 band; and HPLC with evaporative light-scattering detection, which detects the non-UV-absorbing anion by mass. Ion chromatography with conductivity detection is the fourth common method and is the one most contract laboratories use for a certificate.
The counter-ion figure then feeds the net peptide content. A complete content calculation subtracts water (by Karl Fischer titration or loss on drying), counter-ion and any other non-peptide mass from the gross weight. The 2025 study made this point explicitly: because the amount of bound counter-ion depends on the number of positive charges in the sequence, it must be quantified for each peptide and stated, and the salt form must be specified in any assay that compares peptides. A purity figure of 99 percent by HPLC says nothing about how much of the powder is counter-ion; see how to read a certificate line by line for where each number sits.
How the salt form should be declared
A certificate should name the salt form in the product identity and report the counter-ion content as a percentage of mass, so that the net peptide content can be reconstructed. The table lists what a complete declaration contains.
| Certificate element | Complete declaration | Incomplete declaration |
|---|---|---|
| Product name | "Peptide X acetate" or "Peptide X trifluoroacetate salt" | "Peptide X" with no salt stated |
| Counter-ion content | Percent by mass, with method (ion chromatography, 19F-NMR) | Absent, or "TFA removed" with no residual figure |
| Water content | Percent by Karl Fischer | Absent |
| Net peptide content | Percent, derived from the above or from amino acid analysis | Confused with HPLC purity |
| Label mass | Stated as gross vial fill or as net peptide, and which one is clear | Ambiguous |
Two practical notes follow from the literature. First, "TFA-free" is a relative claim. GenScript's standard exchange brings TFA to around 10 percent and its guaranteed service to below 1 percent; a certificate that reports a residual number is more useful than one that reports a word. Second, exchange is a second process step with its own risks, and a laboratory that needs a particular salt form for an infrared study or a sensitive cell assay is better served by a vendor that states the form and the residual than by one that is silent. US Prime Peptides reports net peptide content on every lot-matched certificate alongside identity and HPLC purity, which is where the salt-form question is answered for each product.
Frequently Asked Questions
Why do synthetic peptides come as TFA salts?
Because trifluoroacetic acid is used both to cleave the peptide from the synthesis resin and as the ion-pairing agent in reversed-phase HPLC purification. When the purified fractions are lyophilized, the volatile acid leaves but trifluoroacetate anions paired with the peptide's basic sites remain, typically 10 to 45 percent of the powder's mass.
Does TFA in a peptide affect cell culture experiments?
It can. Cornish and colleagues (1999) found that trifluoroacetate at 10-8 to 10-7 molar reduced proliferation of osteoblasts and chondrocytes in culture, and that TFA salts of several peptides gave lower proliferation than the hydrochloride salts of the same peptides. Later studies reported counter-ion effects on a glycine receptor and on antimicrobial peptide activity.
How is TFA removed from a peptide?
The usual method is repeated lyophilization from dilute hydrochloric acid; two studies found 2 to 10 millimolar HCl removes essentially all TFA without altering peptide structure. Ion-exchange resin, reversed-phase HPLC with an acetate mobile phase, or a deprotonation and reprotonation cycle can install acetate instead of chloride.
Is acetate or TFA better for a research peptide?
For in vitro biological work, manufacturer technical notes recommend acetate because acetic acid is a far weaker acid than TFA or HCl, and acetate is the form used for most approved peptide drug substances. The more important point is that the salt form and residual counter-ion be declared, since both change the net peptide content.
Citations
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277:E779-E783. PMID 10567002
- Roux S, Zékri E, Rousseau B, Paternostre M, Cintrat JC, Fay N. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches. J Pept Sci. 2008;14:354-359. PMID 18035848
- Andrushchenko VV, Vogel HJ, Prenner EJ. Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides. J Pept Sci. 2007;13:37-43. PMID 17031869
- Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals (Basel). 2025;18:1163. PMID 40872554
- Sikora K, Jaśkiewicz M, Neubauer D, et al. Counter-ion effect on antistaphylococcal activity and cytotoxicity of selected antimicrobial peptides. Amino Acids. 2018;50:609-619. PMID 29307075
- Tipps ME, Iyer SV, John Mihic S. Trifluoroacetate is an allosteric modulator with selective actions at the glycine receptor. Neuropharmacology. 2012;63:368-373. PMID 22548713
- Gaussier H, Morency H, Lavoie MC, Subirade M. Replacement of trifluoroacetic acid with HCl in the hydrophobic purification steps of pediocin PA-1: a structural effect. Appl Environ Microbiol. 2002;68:4803-4808. PMID 12324323
- GenScript. TFA Exchange Service (technical note on default TFA salt content and exchange to hydrochloride, acetate or formate). genscript.com
- JPT Peptide Technologies. TFA Removal Service: How to Remove TFA from Peptides (technical note). jpt.com
This article is for laboratory research reference only. US Prime Peptides products are supplied strictly for in vitro research. Not for human consumption.
Related research
- Why Some Peptides Dissolve Badly: Hydrophobicity, Aggregation, and Net Charge
- Reconstitution as Chemistry: Concentration, Solubility, and pH
- How to Vet a Research Peptide Vendor: A 12-Point Checklist
- What a Lot Number Is For, and How to Match a Vial to Its Certificate
- Net Peptide Content vs Purity: Why a 99% Pure Vial Can Hold Less Peptide Than You Think
Compliance Notice: US Prime Peptides products are supplied strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution’s safety protocols and applicable laws.
